R&D History

PATA-X 发布

Start of organoid technology research with National Institute of Animal Science

Development of Next-Generation Biobased Material PATA-X

Launch of companion animal and livestock products

Joint commercialization of antiviral postbiotic (Bifido Co.)

Development and commercialization of novel biomaterial-based products (VeganBiguning)

Food tech and novel biomaterial product development (Kojubu C&F)

Selected for infectious disease prevention technology development project (Ministry of Health)

Green bio commercialization based on smart food tech (Seoul F&B)

Development of broad-spectrum antiviral large-scale production process optimization (AVANTOR)

Broad-spectrum antiviral therapeutic and swine viral disease development (KRIBB)

Marine virus control and marine biotics development project (Ministry of Oceans)

Broad-spectrum antiviral therapeutic development via Bifidobacterium expression platform (Bifido Co.)

Broad-spectrum antiviral therapeutic development (Bioplus Co.)

Development of human and animal antiviral therapeutics (Kifron Bio Co.)

Joint research on oral inhalation device for respiratory virus treatment (Crucialtec)

Selected for animal disease technology development project (Ministry of Agriculture)

Commercialization and applied technology development of functional foods (Presence World)

Initiation of Novel therapy project — development of combined antiviral therapeutics

Establishment of scFv mass production conditions

Demonstration of scFv penetration capability in intestinal and pulmonary mucosa

Verification of viral treatment efficacy using scFv-expressing intestinal bacteria

Analysis of scFv physical properties for viral therapeutic development

Elucidation of cell molecular biology mechanism of scFv viral treatment process

Development of scFv-expressing transgenic pigs and chickens

Demonstration of intrinsic intracellular penetration capability of scFv

Development of scFv-expressing transgenic mice for efficacy verification

Verification of antiviral effects against 7 types of animal viruses

Development of scFv-expressing transgenic tobacco, cabbage, potato, rice, and cactus

Discovery of antiviral effects against 7 types of plant viruses

Isolation of scFv with nucleic acid hydrolyzing capability and elucidation of 3D structure

Commencement of scFv screening research for combined antiviral therapeutic development